SUBSCRIBE
SUBSCRIBE

IPO

Amneal and Impax to Marry, Creating the 5th Larges
Deals
Cancer Biotech Apellis Pharma Sets Terms for $150M IPO
The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15.
October 31, 2017
 · 
1 min read
Deals
Siemens Summons Three Banks for IPO of Healthineers Unit
Siemens AG is looking to take its Healthineers unit public.
October 26, 2017
 · 
2 min read
 · 
Alex Keown
Gemini Therapeutics Banks $42.5M to Bring Precisio
Deals
Ablynx Banks $200M IPO in Nasdaq Debut
Ablynx announced the price of its U.S. IPO at $17.50.
October 25, 2017
 · 
2 min read
 · 
Mark Terry
Investor
Deals
Massachusetts Upstart scPharmaceuticals Files for $100M IPO
scPharmaceuticals filed recently with the SEC regarding its plans for an IPO.
October 24, 2017
 · 
2 min read
 · 
Mark Terry
Deals
Allena Pharma Eyes $92 Million Despite Failed Mid-Stage Trial
October 9, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Deals
26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode
September 26, 2017
 · 
2 min read
Deals
Sisram Medical, Majority-Owned By Fosun Pharma, Stages $125 Million Hong Kong IPO
September 22, 2017
 · 
1 min read
Deals
Zai Lab Completes $150 Million IPO; Stock Jumps 50% At Opening; Company Worth $1.4 Billion
September 20, 2017
 · 
1 min read
Deals
OptiNose Files for $100 Million IPO
September 19, 2017
 · 
1 min read
Deals
Massachusetts’ Deciphera Seeks $100 Million IPO
September 19, 2017
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
 · 
3 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
 · 
4 min read
Press Releases
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 6, 2026
 · 
2 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
 · 
3 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
 · 
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
 · 
4 min read
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
 · 
3 min read
Press Releases
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
December 30, 2025
 · 
12 min read
Press Releases
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
December 22, 2025
 · 
5 min read
Press Releases
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
 · 
4 min read
Press Releases
Medline Announces Pricing of Upsized Initial Public Offering
December 17, 2025
 · 
4 min read
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
 · 
3 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
 · 
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
 · 
4 min read
Press Releases
Lumexa Imaging Announces Launch of Initial Public Offering
December 2, 2025
 · 
2 min read
Press Releases
Hemostemix Closes CDN$280,594 Private Placement
November 19, 2025
 · 
1 min read
Press Releases
NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
November 19, 2025
 · 
1 min read
Press Releases
Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering
November 18, 2025
 · 
5 min read
Press Releases
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter’s Option to Purchase Additional Shares
November 11, 2025
 · 
1 min read
Press Releases
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 10, 2025
 · 
2 min read
Load More